Before all the goody two-shoes here start attacking those of us who do not like the fact that they have not yet released the top line results, and we are February 1 in case you have not noticed, try to respond to the following comments without the sarcasm.
1) Originally, top line results were due last year, so we have already slipped by a month but I do not consider that to be a big deal on account of enrollment delays. However, further delays would become worrisome at this stage since the last patient was enrolled by Jan 7 and I have to assume that all the pertinent top line data is currently in the hands of GTCB. So please educate us "ignorants" as to why they are sitting on it!
2) While we all agree that positive top line data is extremely likely, and should propel the stock forward, there is still a small chance that the top line data is not as good as expected, especially with such a low number of patients. We can dance around the topic as much as we want but negative top line data at this time would be disastrous for GTCB because it could affect all their ATryn programs for HD as well as Sepsis both here and in the EU. If this stock had options on it, I would have certainly by now bought some cheap protective puts just in case. Unfortunately, this is not the case so we are all taking a chance here, a well worth it chance but a chance nevertheless. So I think we should stop criticizing those that are expressing some angst against this delay because I am 100% sure the delay is making us all a bit nervous...
3) While most of you do not give the NASDAQ listing issue much importance, it is nevertheless noteworthy that we have already been above the $1 at the close for 7 consecutive trading days. If we can keep this up through Tuesday then the delisting threat disappears. Hence, if we want to think suspiciously, we could conjecture that management has decided to keep the top line results secret through Tuesday in order to put the delisting threat behind them because they are by now aware that the results could tank the stock. Far fetched and overly suspicious? Maybe but it is still a possibility that becomes more and more plausible with every passing day without top line data...
In spite of all the above fears, I am holding on to my position after having unloaded some above the $1.1 mark this week. If the stock drops more, I may buy back the shares I unloaded recently. I still think the risk/reward is very favorable for GTCB but I am getting more and more nervous with every pasiing day with no top line results...
AI
Market Data 
Markets 
